Matches in Wikidata for { <http://www.wikidata.org/entity/Q81094230> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q81094230 description "artículu científicu espublizáu n'agostu de 2005" @default.
- Q81094230 description "im August 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81094230 description "scientific article published on 01 August 2005" @default.
- Q81094230 description "wetenschappelijk artikel" @default.
- Q81094230 description "наукова стаття, опублікована в серпні 2005" @default.
- Q81094230 name "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 name "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 type Item @default.
- Q81094230 label "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 label "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 prefLabel "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 prefLabel "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 P1433 Q81094230-4BFDE7E7-16CD-4BE8-805A-0C4D0C0CBAE1 @default.
- Q81094230 P1476 Q81094230-4AE36A9D-F950-423E-B177-B379DA3B476B @default.
- Q81094230 P2093 Q81094230-250FA222-C1B8-4C64-B291-59BE8B725AE8 @default.
- Q81094230 P2093 Q81094230-5CAD5230-1A49-4C19-9B51-2771766E1026 @default.
- Q81094230 P2093 Q81094230-6851DE6D-DD82-47BD-900D-D4ED45E84DC6 @default.
- Q81094230 P2093 Q81094230-87200485-5FAE-49F7-A12F-EBBE1B7A3BD0 @default.
- Q81094230 P2093 Q81094230-AE22E448-E331-4ED7-84E9-8E1B709FFD55 @default.
- Q81094230 P2093 Q81094230-C3678E95-37C2-45B7-9A0A-F485952F8EB7 @default.
- Q81094230 P2093 Q81094230-F91CD85C-9DBB-414A-A454-C9C896BC131F @default.
- Q81094230 P304 Q81094230-05B53563-EF3E-4630-BCA5-4272F14071CE @default.
- Q81094230 P31 Q81094230-46ABD753-7387-4BAD-9236-66F507DD1F9B @default.
- Q81094230 P356 Q81094230-A059F0CA-A62F-444D-A485-8A802E2D2B36 @default.
- Q81094230 P433 Q81094230-7537D15B-B60B-46B3-8FDE-43147869F938 @default.
- Q81094230 P478 Q81094230-61C78DE2-5002-4BD9-99D7-8014F1F68E99 @default.
- Q81094230 P577 Q81094230-26DE61B5-A3A9-4672-BE52-F2B4C9EF89C7 @default.
- Q81094230 P698 Q81094230-F2948710-1CDE-426F-BA3F-6884859CCABE @default.
- Q81094230 P921 Q81094230-D9DB5009-B1D6-472D-843D-B77CEB901B74 @default.
- Q81094230 P356 TH04-12-0835 @default.
- Q81094230 P698 16113834 @default.
- Q81094230 P1433 Q15724413 @default.
- Q81094230 P1476 "Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction" @default.
- Q81094230 P2093 "Heinz-Peter Schultheiss" @default.
- Q81094230 P2093 "Jana Priess" @default.
- Q81094230 P2093 "Markus Jaster" @default.
- Q81094230 P2093 "Michael Piorkowski" @default.
- Q81094230 P2093 "Peter-Lothar Schwimmbeck" @default.
- Q81094230 P2093 "Ulf Weikert" @default.
- Q81094230 P2093 "Ursula Rauch" @default.
- Q81094230 P304 "422-426" @default.
- Q81094230 P31 Q13442814 @default.
- Q81094230 P356 "10.1160/TH04-12-0835" @default.
- Q81094230 P433 "2" @default.
- Q81094230 P478 "94" @default.
- Q81094230 P577 "2005-08-01T00:00:00Z" @default.
- Q81094230 P698 "16113834" @default.
- Q81094230 P921 Q18558122 @default.